OP-116 Assessing the Relationship between Serum NT-Probnp and Left Ventricular Myocardial Viability by Cardiac MRI and Transthoracic Parameters




Background


Cardiac MRI is the preferred method for determining myocardial viability. However, due to its high cost and limited availability, we describe an alternative method with acceptable accuracy to predict myocardial viability. Our experience with the relationship between serum NT Pro-BNP and left ventricular myocardial viability by cardiac MRI and Transthoracic echocardiography (TTE) is reported.




Methods


From September 2012 to March 2014, in a single-center, cross sectional study, cardiac MRI determined 30 patients for myocardial assessment. Before cardiac MRI, Transthoracic echocardiography and a serum sample were taken for NT Pro-BNP level measurement. Left ventricle scar tissue index was defined for cardiac MRI and different transthoracic echocardiography parameters were used to report TTE changes.




Methods


From September 2012 to March 2014, in a single-center, cross sectional study, cardiac MRI determined 30 patients for myocardial assessment. Before cardiac MRI, Transthoracic echocardiography and a serum sample were taken for NT Pro-BNP level measurement. Left ventricle scar tissue index was defined for cardiac MRI and different transthoracic echocardiography parameters were used to report TTE changes.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 30, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-116 Assessing the Relationship between Serum NT-Probnp and Left Ventricular Myocardial Viability by Cardiac MRI and Transthoracic Parameters

Full access? Get Clinical Tree

Get Clinical Tree app for offline access